SPRINT fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Sprint Bioscience AB is a pharmaceutical company, which engages in the research and development of drug for cancer. It offers product which focuses on the tumor metabolism, diabetes, and non-alcoholic steatohepatitis. The company was founded by Anders Aberg, Par Nordlund, Martin Andersson, Jessica Martinsson, and Kenth Hallberg in 2009 and is headquartered in Huddinge, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
SPRINT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company